Dake Benjamin T — SEC Form 4 filings
SEC reporting owner CIK 1869248. 7 Form 4 filings on record with FilingPulse; latest filed 2024-08-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-24 to 2024-08-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 59,735 shares, $1,573,327 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 27,476 shares @ $25.74 ($707,282) in Aerovate Therapeutics, Inc., filed 2024-03-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. (AVTE) | SEE REMARKS | 7 | — | 8 legs · 59,735 sh · $1,573,327 | 18 |
Form 4 filings — Dake Benjamin T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-02 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 11,454 @ $1.74 · Option exercise (M): 1,507 @ $1.74 · Option exercise (M): 906 (derivative) @ $0 · Option exercise (M): 10,548 (derivative) @ $0 · Option exercise (M): 1,507 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 6,853 @ $2.14 · Sale (S): 6,447 @ $22.32 · Sale (S): 338 @ $23.17 · Sale (S): 68 @ $23.97 · Option exercise (M): 6,853 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 3,325 @ $10.61 · Sale (S): 3,325 @ $31.97 · Option exercise (M): 3,325 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 11,068 @ $10.61 · Sale (S): 11,068 @ $27.97 · Option exercise (M): 11,068 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 3,432 @ $10.61 · Sale (S): 3,432 @ $28.01 · Option exercise (M): 3,432 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Option exercise (M): 20,557 @ $2.14 · Option exercise (M): 14,500 @ $10.61 · Sale (S): 27,476 @ $25.74 · Sale (S): 7,581 @ $26.48 · Option exercise (M): 20,557 (derivative) @ $0 · Option exercise (M): 14,500 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Aerovate Therapeutics, Inc. (AVTE) | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1869248 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →